Sunny Hirpara, PharmD

Clinical Account Director
Biopharmaceuticals, Global Patient Safety, AstraZeneca, Wilmington, DE, United States

Poster(s):

• (404) Efficacy of as-needed albuterol–budesonide versus albuterol on systemic corticosteroid exposure in participants with mild asthma: BATURA prespecified analysis
  Wednesday, October 29, 2025